SPY300.77-2.20 -0.73%
DIA252.12-2.23 -0.88%
IXIC9,338.05-30.94 -0.33%

B. Riley FBR Maintains Buy on TG Therapeutics, Raises Price Target to $37

B. Riley FBR maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target from $29 to $37.

Benzinga · 05/18/2020 12:04

B. Riley FBR maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target from $29 to $37.